Literature DB >> 2197496

Transdermal oestrogene application a contraindication in therapy of endometriosis with gonadotropin-releasing hormone analogues.

A Rosen1, M Klein, A Beck.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2197496     DOI: 10.1007/bf01648254

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


× No keyword cloud information.
  6 in total

1.  The hormonal response of endometerium in endometriotic implants and its relationship to symptomatology.

Authors:  J W RODDICK; G CONKEY; E J JACOBS
Journal:  Am J Obstet Gynecol       Date:  1960-06       Impact factor: 8.661

2.  A new treatment for endometriosis.

Authors:  P Maouris; M Dowsett; G Rose; D K Edmonds
Journal:  Lancet       Date:  1989-05-06       Impact factor: 79.321

3.  Hypogonadism induced by luteinising hormone releasing hormone agonist analogues: effects on bone density in premenopausal women.

Authors:  W H Matta; R W Shaw; R Hesp; D Katz
Journal:  Br Med J (Clin Res Ed)       Date:  1987-06-13

4.  New therapy for endometriosis.

Authors:  R L Barbieri
Journal:  N Engl J Med       Date:  1988-02-25       Impact factor: 91.245

5.  Endometriosis: role of ovarian steroids in initiation, maintenance, and suppression.

Authors:  G S Dizerega; D L Barber; G D Hodgen
Journal:  Fertil Steril       Date:  1980-06       Impact factor: 7.329

6.  "Medical oophorectomy" using a long-acting GNRH agonist--a possible new approach to the treatment of endometriosis.

Authors:  D R Meldrum; R J Chang; J Lu; W Vale; J Rivier; H L Judd
Journal:  J Clin Endocrinol Metab       Date:  1982-05       Impact factor: 5.958

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.